| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.CIR.93.3.440 |
| P698 | PubMed publication ID | 8565160 |
| P2093 | author name string | A Evans | |
| D Arveiler | |||
| F Green | |||
| F Cambien | |||
| G Luc | |||
| P Y Scarabin | |||
| V Nicaud | |||
| J P Cambou | |||
| L Bara | |||
| O Poirier | |||
| I Behague | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | coronary artery disease | Q844935 |
| P304 | page(s) | 440-449 | |
| P577 | publication date | 1996-02-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Etude Cas-Temoins sur l'Infarctus du Myocarde | |
| P478 | volume | 93 |
| Q59697020 | A Polymorphic Cluster in the 5′ Region of the Human Coagulation Factor VII Gene: Detection, Frequency, and Linkage Disequilibrium |
| Q37369178 | A common mutation (G-455--> A) in the beta-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9,127 individuals based on the Copenhagen City Heart Study |
| Q34273571 | A genetic instrument for Mendelian randomization of fibrinogen. |
| Q40573006 | A genome-wide search for genes affecting circulating fibrinogen levels in the Framingham Heart Study |
| Q92282554 | Analysis of Differentially Expressed Genes in Coronary Artery Disease by Integrated Microarray Analysis |
| Q44739970 | Angiotensin-converting enzyme genotype, albuminuria and plasma fibrinogen in type 2 diabetes mellitus |
| Q79230526 | Association Study of CD14 Polymorphism With Myocardial Infarction in a Japanese Population |
| Q77676889 | Association between polymorphisms in the fibrinogen alpha- and beta-genes on the post-trauma fibrinogen increase |
| Q37720279 | Association of fibrinogen with severity of stable coronary artery disease in patients with type 2 diabetic mellitus |
| Q80524458 | Association of genetic polymorphisms in the fibrinogen and platelet glycoprotein genes with unstable angina in Chinese patients |
| Q36514594 | Associations of the beta-fibrinogen Hae III and factor XIII Val34Leu gene variants with venous thrombosis |
| Q47906849 | Asymptomatic carriership of factor V Leiden and genotypes of the fibrinogen gene cluster |
| Q43568575 | Beta-fibrinogen gene -455G/A polymorphism and coronary heart disease incidence: the Atherosclerosis Risk in Communities (ARIC) Study |
| Q37176377 | Cerebral small vessel disease: genetic risk assessment for prevention and treatment |
| Q41492376 | Coronary heart disease and genetics in epidemiologist's view |
| Q74465122 | Effect of genetic background and diet on plasma fibrinogen in mice. Possible relation with susceptibility to atherosclerosis |
| Q34106488 | Effects of HMG-CoA reductase inhibitor on hemostasis |
| Q44071017 | Effects of short-term atorvastatin treatment on global fibrinolytic capacity, and sL-selectin and sFas levels in hyperlipidemic patients with coronary artery disease |
| Q44305984 | Familial hypofibrinogenaemia associated with heterozygous substitution of a conserved arginine residue; Bbeta255 Arg-->His (Fibrinogen Merivale). |
| Q46787524 | Fibrinogen and clot-related phenotypes determined by fibrinogen polymorphisms: Independent and IL-6-interactive associations |
| Q33739135 | Fibrinogen and women's health |
| Q50907848 | Fibrinogen is an independent marker for thoracic aortic atherosclerosis. |
| Q57998359 | Frequency distribution of the G/A alleles of the β-fibrinogen gene in the Lebanese population |
| Q43971013 | Genes and coronary heart disease |
| Q52860275 | Genetic regulation of fibrin structure and function: complex gene-environment interactions may modulate vascular risk. |
| Q34429646 | Heterozygosity for fibrinogen results in efficient resolution of kidney ischemia reperfusion injury |
| Q91672343 | High factor VIII levels and arterial thrombosis: illustrative case and literature review |
| Q73681235 | Identification of a BamHI Polymorphism for the Urokinase Gene Associated with Symptomatic Coronary Artery Disease |
| Q45879887 | Identification of four novel polymorphisms in the Aalpha and gamma fibrinogen genes and analysis of association with plasma levels of the protein |
| Q35542242 | Inherited Thrombophilia: Impact on Human Reproduction |
| Q35490349 | Investigation of factors which might indicate susceptibility to particulate air pollution |
| Q35053963 | Large scale association analysis for identification of genes underlying premature coronary heart disease: cumulative perspective from analysis of 111 candidate genes |
| Q64058650 | Mendelian randomization evaluation of causal effects of fibrinogen on incident coronary heart disease |
| Q36843011 | Molecular genetics of myocardial infarction |
| Q95777601 | Multi-locus interactions predict risk for post-PTCA restenosis: an approach to the genetic analysis of common complex disease |
| Q82993512 | Multiple thrombophilic gene mutations are risk factors for implantation failure |
| Q81204225 | Plasma fibrinogen level: an independent risk factor for long-term survival in Chinese patients with peripheral artery disease? |
| Q41682753 | Polymorphisms of coagulation/fibrinolysis genes: gene environment interactions and vascular risk |
| Q77714696 | Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention |
| Q33857984 | Prevention of coronary heart disease. Part II. Secondary prevention, detection of subclinical disease, and emerging risk factors |
| Q35113270 | Prothrombotic determinants of coronary atherothrombosis |
| Q50967816 | Risk factors associated with the development of peripheral arterial disease in smokers: a case-control study. |
| Q36735715 | Role of genetic changes in the progression of cardiovascular diseases |
| Q47664095 | Selective pressure has not acted against hypercoagulability alleles in high-altitude Amerindians |
| Q41993571 | Sequence diversity in 36 candidate genes for cardiovascular disorders |
| Q34346972 | Study of associated genetic variants in Indian subjects reveals the basis of ethnicity related differences in susceptibility to venous thromboembolism |
| Q73712803 | T102C polymorphism of the serotonin (5-HT) 2A receptor gene in patients with non-fatal acute myocardial infarction |
| Q57393886 | The G-455A polymorphism of the fibrinogen Bbeta-gene relates to plasma fibrinogen in male cases, but does not interact with environmental factors in causing myocardial infarction in either men or women |
| Q50851387 | The Gln-Arg 191 polymorphism of the human paraoxonase gene is not associated with the risk of coronary artery disease among Chinese in Taiwan. |
| Q35736976 | The Prevalence of the Prothrombin (F2) 20210G>A Mutation in a Cohort of Sri Lankan Patients with Thromboembolic Disorders |
| Q64134027 | The beta fibrinogen gene G-455-A polymorphism is a risk factor for Legg-Perthes disease |
| Q44040257 | The contribution of genetic factors to thrombotic and bleeding outcomes in coronary patients randomised to IIb/IIIa antagonists |
| Q33918597 | Thrombophilia, polymorphisms, and vascular disease |
| Q74582774 | Under-representation of the -455A beta-fibrinogen allele in survivors of pulmonary embolism |
| Q44109228 | Variables associated with fibrinogen in a population-based study: interaction between smoking and age on fibrinogen concentration |
| Q73118426 | [Blood coagulation, genetics and post-angioplasty restenosis] |
| Q34039526 | Βeta-fibrinogen gene promoter A -455 allele associated with poor longterm survival among 55-71 years old Caucasian women in Finnish stroke cohort |
Search more.